ABOUT US

Company Overview

A Subsidiary of ACI PLC

ACI HealthCare Limited operates as a specialized public limited subsidiary of Advanced Chemical Industries (ACI) PLC, a leading diversified conglomerate in Bangladesh with a heritage dating back to 1973. This legacy, rooted in the evolution of Imperial Chemical Industries (ICI) in Bangladesh, reflects decades of experience in pharmaceuticals, science-based industries, and disciplined corporate governance.

As part of ACI PLC, ACI HealthCare Limited benefits from a strong institutional foundation characterized by structured governance, operational excellence, and a commitment to quality and innovation. This affiliation enables the company to align with global regulatory expectations and maintain a strategic focus on regulated-market manufacturing. Leveraging the group's legacy and capabilities, ACI HealthCare Limited is positioned to strengthen Bangladesh's pharmaceutical presence in international markets while ensuring sustainable growth, compliance, and long-term value creation for global stakeholders.

Image of ACI Healthcare Factory

Image of ACI PLC Corporate Office (ACI Center)

“ ”

Our Mission

To achieve business excellence through quality by planning, implementing, controlling and improving the standards of its products & services for exceeding customer expectations on continuous basis.

Our Vision

To play a leading role in improving the quality of life and well-being of the people through responsible application of knowledge and skills.

Our Core Values

Quality

Continous
Improvement

Customer focus

Transparency

Fairness

Innovation

Our Corporate Milestone

1973

Establishment Of Imperial Chemical Industries (ICI) Bangladesh.

1992

Transition to Advanced Chemical Industries (ACI) Limited.

2013

Establishment of ACI HealthCare Limited.

2017

Formation of ACI HealthCare USA Inc.

2017–2019

Commissioning of GMP-compliant manufacturing facility.

2022

US FDA approval achieved.

2022-2023

Direct exports to the United States initiated.

2023

Expansion into European markets.

2024

WHO Prequalification achievement for Azithromycin Tablets.

2025 and beyond

Pipeline expansion and global regulatory growth.

Our Strategic Pillars

Regulated-Market
Focus

Regulated-market-aligned quality frameworks ensuring compliance with US FDA, EMA, WHO, Health Canada, and global GMP standards.

Innovation for Global
Access

Strategic pipeline aligned with global healthcare needs and long-term technology-enabled innovation.

Advanced Manufacturing
System

Modern manufacturing and analytical systems delivering consistent, reliable, and scalable production performance.

Leadership & Governance

Our leadership team combines global insights with deep expertise to guide ACI HealthCare Limited toward a future of innovation and excellence. By focusing on smart execution and sustainable growth, they are dedicated to making a lasting, positive impact on community health.

Mr. M. Anis Ud Dowla, the Chairman of ACI Group, is one of the most successful personalities in Bangladesh business circle. Mr. Dowla has maintained a high profile, and has provided leadership to the business community in different capacities. Mr. Dowla served in the British Oxygen Group of UK in Pakistan, Bangladesh and Kenya for 27 years, including 12 years as Managing Director of Bangladesh Oxygen Ltd. In 1987, he became the Group Managing Director of the three ICI companies in Bangladesh. With experience gathered while working with two British multi-nationals for over 32 years, Mr. Dowla has continued to maintain the multinational culture and management style in ACI, with special emphasis on quality, productivity and customer services. He was the President of Metropolitan Chamber of Commerce & Industries, Dhaka in 1977, 1978, 1995 and 2010. Mr. Dowla has considerable contribution in the field of Industrial Relations of the country. He was elected President of Bangladesh Employers' Federation for the terms in 1975-1976, 1976-1977, 1991-1992, 1992-1993, 2003-2004 and 2004-2005. He is the President of the Bangladesh Seed Association. He is the Chairman of Pioneer Insurance Company Limited and Director of the Credit Rating Agency of Bangladesh. He is as well a member of the Board of Trustees of the Independent University of Bangladesh and the President of Bangladesh Association of Publicly Listed Companies.

Professional Foundation

1960 - 1986

Mr. Dowla began his career in 1960 with Pakistan Oxygen Limited (a subsidiary of the British Oxygen Company – BOC) as an Assistant Sales Manager. Over the next 27 years, he held leadership roles across Bangladesh, Pakistan, and Kenya, gaining extensive experience in industrial operations and multinational management.

1971 and onwards

Following Bangladesh’s independence, he became the first Bangladeshi Managing Director of Bangladesh Oxygen Limited and led the company through a critical post-war industrial phase, ensuring operational continuity and growth.

Transformation From ICI To ACI

In 1987, Mr. Dowla joined Imperial Chemical Industries (ICI) Bangladesh as Group Managing Director. In 1992, he led a landmark management buyout of ICI’s Bangladesh operations, establishing Advanced Chemical Industries (ACI) as a fully locally owned organization.

Under his leadership, ACI evolved from a modest operation with limited workforce and turnover into a diversified conglomerate with significant presence across pharmaceuticals, healthcare, agribusiness, consumer goods, and retail.

The organization introduced several pioneering initiatives, including early adoption of international quality standards and expansion into new industrial and commercial sectors, setting benchmarks for corporate governance and operational excellence in Bangladesh.

Awards And Recognition

Mr. Dowla’s contributions have been widely recognized through national and business awards, including:

Business Person of the Year (2017)
Best Entrepreneur Award (2011)
Bangabandhu Jatiyo Krishi Puroshkar (Gold Medal)
Lifetime Achievement Award – DHL–The Daily Star Business Awards (2024)

Under his leadership, ACI has also received recognition as one of the most respected companies in Bangladesh, reflecting his emphasis on quality, ethics, and long-term value creation.